This is a possibility in the short term. There are many uses for this drug in the states, but without FDA approval, this will be a chore and time consuming. Maybe another country will take a chance on it. Who knows? With the data, I'll be happy for a buyout at $.08.
ps. I took a few days off of work to stew about the data, but realized that the answer to my problem will be not working less but working more. Two more years of working and grinding at this point, but all good. We took a chance and now just sit and wait for a miracle, a long haul study, a buyout, a partnership, a reverse split, a sale of one unit of Bucy somewhere, or bankruptcy.
pps. Final Blackjack scenario: We now have a 16 against an ace.